Telmisartan Market - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for therapy of hypertension, in cardiac arrest, and in stroke management. Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. The typical dose of Telmisartan in adults is 40 to 80 mg once daily, and it is used long term. Telmisartan is also available in fixed combinations with hydrochlorothiazide, and amlodipine.

Market Dynamics

Prevalence of high blood pressures, is increasing globally attributed to rising geriatric population, chronic disorders such as diabetes, and changing lifestyles which in turn is expected to increase the demand for telmisartan in global market. According to Blood Pressure UK, 2021 update, high blood pressure is the leading cause of heart disease and stroke, killing around 7.5 million people worldwide every year. In 1975, 594 million people were suffering from high blood pressure which increased to 1.1 billion in 2015 and is thought to be due to population growth and an aging population. Thus, rise in geriatric population suffering from high blood pressure is expected to be major factor for growth of telmisartan market in the forecast period.

Furthermore, increasing approvals for Abbreviated new Drug Application (ANDA) for manufacturing of generic telmisartan tablets is propelling growth of telmisartan in the global market. For instance, in July 2014, Glenmark Generics Inc., USA-a subsidiary of Glenmark Generics Limited-received ANDA approval from the U.S. Food and Drug Administration (USFDA) for telmisartan tablets.

Key features of the study:

This report provides in-depth analysis of the telmisartan market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global telmisartan market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Glenmark Generics Inc., Torrent Pharmaceuticals Ltd., Solco Healthcare U.S., Mylan Inc., Aurobindo Pharma Limited, Yichang Changjiang Pharmaceutical Co., Ltd, Wanbang Biopharmaceuticals, and Nippon Boehringer Ingelheim Co., Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global telmisartan market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for telmisartan market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
Global Telmisartan Market, By Composition:
- Single
- Combinational
Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Telmisartan Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
  - Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
  - Global Telmisartan Market, By Composition:
- Single
- Combinational
  - Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
  - Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
  - Global Telmisartan Market, By Composition:
- Single
- Combinational
  - Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
  - Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
  - Global Telmisartan Market, By Composition:
- Single
- Combinational
  - Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
  - Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
  - Global Telmisartan Market, By Composition:
- Single
- Combinational
  - Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
  - Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
  - Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
  - Global Telmisartan Market, By Composition:
- Single
- Combinational
  - Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
  - Global Telmisartan Market, By Strength:
- 20mg
- 40mg
- 80mg
  - Global Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
  - Global Telmisartan Market, By Composition:
- Single
- Combinational
  - Global Telmisartan Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles
- C.H. Boehringer Sohn AG & Ko. KG *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Glenmark Generics Inc.
- Torrent Pharmaceuticals Ltd.
- Solco Healthcare U.S.
- Aurobindo Pharma Limited
- Mylan Inc.
- Yichang Changjiang Pharmaceutical Co., Ltd
- Wanbang Biopharmaceuticals.
- Nippon Boehringer Ingelheim Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2524

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Strength
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Pipeline Analysis
Epidemiology
Historical Overview
Merger and Acquisition
Regulatory Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Telmisartan Market, By Strength, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
20mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
40mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
80mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Telmisartan Market, By Indication, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cardiac Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Telmisartan Market, By Composition, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Single
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Combinational
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Telmisartan Market, By Distribution Channel, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Telmisartan Market, By Regions, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Strength, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Strength, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Strength, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Strength, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Strength, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Northern Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Strength, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East

9. Competitive Landscape

Heat Map Analysis
Company Profiles
- C.H. Boehringer Sohn AG & Ko. KG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Glenmark Generics Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Torrent Pharmaceuticals Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Solco Healthcare U.S.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Aurobindo Pharma Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Yichang Changjiang Pharmaceutical Co., Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Wanbang Biopharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Nippon Boehringer Ingelheim Co., Ltd.
- Company Overview.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
Analyst Views

10. Section

References
Research Methodology
About us and Sales Contact

Telmisartan Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028